Unadjusted plots of the annual proportions of patients meeting the quality measures suggest that, compared to non-cancer controls, (A) slightly lower proportions of prostate cancer patients achieved cholesterol control (total cholesterol ≤5 mmol/L), (B) lower proportions of breast and colorectal cancer patients achieved HbA1c control (HbA1c ≤ 59 mmol/mol), and (C) lower proportions of breast and colorectal cancer patients received an albumin creatinine ratio test—at least during the first year after cancer diagnosis (Fig. 1). Here, ALB is linked to prostate carcinoma.